कोशिश गोल्ड - मुक्त
“Council plans to set up Centres of Excellence”
Bio Spectrum
|April 2020
Established in 2014, Life Sciences Sector Skill Development Council (LSSSDC) is a Non-Statutory Skill Certification Body authorized by Ministry of Skill Development and Entrepreneurship, Government of India.
-

Ranjit Madan, CEO, Life Sciences Sector Skill Development Council, New Delhi
LSSSDC is a not for profit organization, registered under the Societies Act, 1860. As a National level organization, in partnership with various stakeholder groups, it will serve to address the skill shortfalls in the Life Sciences Sector in India. Its aim, over a 10 year period, will be to map all job roles in the Sector (estimated 100), enlist Training Organisations, train the Trainers and certify approx. 2.1 million skilled workers in this Sector.
At the helm is a Governing Body with representation from various Stakeholder groups, including industry (through major Associations such as IPA (Alliance), BDMA, IDMA, CIPI, ABLE, ACRO, OPPI, IRA (Association), FOPF Government, (through Pharmexcil) and Ministry of Health and Family Welfare MOHFW and Academia (NIPER & PCI). Day to day operations are managed by the CEO, Ranjit Madan (a professional, with 30 years corporate sector experience) and his team. As the emphasis on skill development increases, Prapti Shah from BioSpectrum spoke to Ranjit Madan on the work undertaken by LSSDC and the skill gap that exists in India. Edited excerpts;
The Government in Budget 2020 has allocated Rs 3000 crore for skill development. What is your view on this and how will this be helpful to the Life Sciences Sector?
We hope that an appropriate portion of this would be channelized for the Life Sciences sector, which has a direct impact on human life and is one of the major ‘Priority sectors’ as defined by Niti Ayog.
In your opinion, what steps are needed to impart necessary skills to the existing workforce?
यह कहानी Bio Spectrum के April 2020 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 9,500 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
Bio Spectrum से और कहानियाँ

Bio Spectrum
WHO certifies Suriname malaria-free
Suriname became the first country in the Amazon region to receive malaria-free certification from the World Health Organization (WHO).
1 min
August 2025

Bio Spectrum
Torrent Pharma buys controlling stake in JB Pharma from KKR for Rs 25,689 Cr valuation
Ahmedabad-based Torrent Pharmaceuticals and global investment firm KKR have announced that Torrent has entered into definitive agreements to acquire controlling stake in Mumbai-based J. B. Chemicals and Pharmaceuticals (JB Pharma) from KKR at an Equity Valuation of Rs 25,689 crore (on fully diluted basis), followed by a merger of the two entities.
1 min
August 2025
Bio Spectrum
Suraksha Diagnostics injects Rs 22 Cr to establish Eastern India's largest genomics lab
Suraksha Diagnostics, one of the leading diagnostics chains in Eastern India, has launched one of the largest and a state-of-theart genomics lab in Eastern India.
1 min
August 2025
Bio Spectrum
Illumina buys SomaLogic for $425 M to accelerate proteomics business
Illumina, Inc. has entered into a definitive agreement with Standard BioTools under which Illumina will acquire SomaLogic, a leader in data-driven proteomics technology, and other specified assets for $350 million in cash payable at closing, subject to customary adjustments, plus up to $75 million in near-term performance-based milestones and performance-based royalties.
1 min
August 2025

Bio Spectrum
Kashmik Formulation to expand capacity, eyes Rs 100 Cr revenue in FY26
Kashmik Formulation, a pharmaceutical manufacturing company headquartered in Ahmedabad, has announced significant expansion plans aimed at increasing production capacity, strengthening its presence in international markets, and enhancing operational efficiencies through automation.
1 min
August 2025
Bio Spectrum
WHO highlights risks associated with use of semaglutide medicines
The World Health Organisation (WHO) is alerting healthcare professionals and regulatory authorities to the risk of non-arteritic anterior ischemic optic neuropathy (NAION) associated with the use of semaglutide medicinesOzempic, Rybelsus, and Wegovy.
1 min
August 2025

Bio Spectrum
Lamark Biotech secures Rs 6.5 Cr to accelerate development of thermostable insulin
Lamark Biotech, an innovation-led biopharma startup, has raised Rs 6.5 crore in a PreSeries A round led by IAN Group, including IAN Alpha Fund, powered by BioAngels, Dr Vinayender Tulla, Dr Nita Roy, and Venkataraman KNK, domain experts of IAN's angel investors led the round.
1 min
August 2025

Bio Spectrum
AstraZeneca invests Rs 166 Cr to expand Global Hub in Bengaluru
AstraZeneca, a global, science-led biopharmaceutical company, has announced the expansion of its state-of-the-art Global Hub in Bengaluru, strengthening its presence in India.
1 min
August 2025

Bio Spectrum
Novo Nordisk launches injectable Semaglutide for weight management in India
Novo Nordisk, a leading global healthcare company headquartered in Denmark with over a 100-year legacy of chronic disease care, has announced the launch of Wegovy (injectable Semaglutide) in India.
1 min
August 2025

Bio Spectrum
Can Policy Reforms & Investments Trigger India's MedTech MAKEOVER?
India's MedTech sector has long been import-dependent. The Centre is now working to change this by positioning the country as an export-oriented manufacturing hub. A series of policies and investments have been introduced to support this shift. Have these made an impact? What steps are necessary to strengthen India's position in the global medical technology (MedTech) landscape? Let's find out.
12 mins
August 2025
Translate
Change font size